- Home
- CNMD vs PCT Comparison
CNMD vs PCT Comparison
Compare CNMD & PCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNMD
- PCT
- Stock Information
- Founded
- CNMD 1970
- PCT 2015
- Country
- CNMD United States
- PCT United States
- Employees
- CNMD N/A
- PCT N/A
- Industry
- CNMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- PCT Environmental Services
- Sector
- CNMD Health Care
- PCT Utilities
- Exchange
- CNMD Nasdaq
- PCT Nasdaq
- Market Cap
- CNMD 2.2B
- PCT 1.8B
- IPO Year
- CNMD 1987
- PCT N/A
- Fundamental
- Price
- CNMD $67.38
- PCT $10.07
- Analyst Decision
- CNMD Buy
- PCT Strong Buy
- Analyst Count
- CNMD 6
- PCT 4
- Target Price
- CNMD $82.83
- PCT $12.50
- AVG Volume (30 Days)
- CNMD 402.4K
- PCT 1.9M
- Earning Date
- CNMD 01-29-2025
- PCT 11-15-2024
- Dividend Yield
- CNMD 1.18%
- PCT N/A
- EPS Growth
- CNMD 127.53
- PCT N/A
- EPS
- CNMD 4.22
- PCT N/A
- Revenue
- CNMD $1,288,116,000.00
- PCT N/A
- Revenue This Year
- CNMD $6.69
- PCT N/A
- Revenue Next Year
- CNMD $7.53
- PCT $1,669.07
- P/E Ratio
- CNMD $15.96
- PCT N/A
- Revenue Growth
- CNMD 10.23
- PCT N/A
- 52 Week Low
- CNMD $61.05
- PCT $2.39
- 52 Week High
- CNMD $113.68
- PCT $15.58
- Technical
- Relative Strength Index (RSI)
- CNMD 37.75
- PCT 35.10
- Support Level
- CNMD $67.60
- PCT $10.46
- Resistance Level
- CNMD $70.52
- PCT $11.03
- Average True Range (ATR)
- CNMD 2.54
- PCT 0.64
- MACD
- CNMD -0.43
- PCT -0.16
- Stochastic Oscillator
- CNMD 7.64
- PCT 4.12
About CNMD CONMED Corporation
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.
About PCT PureCycle Technologies Inc. Common stock
PureCycle Technologies Inc holds a license to commercialize the only patented solvent-based purification recycling technology, developed by The Procter & Gamble Company (P&G), for restoring waste polypropylene (PP) into a virgin-like resin. The proprietary process removes color, odor, and other contaminants from recycled feedstock resulting in virgin-like polypropylene suitable for any PP market.